Proteoglycans in cancer (hsa05205) |
<0.0001 |
Renal cell carcinoma (hsa05211) |
<0.0001 |
Chronic myeloid leukemia (hsa05220) |
<0.0001 |
Prostate cancer (hsa05215) |
<0.0001 |
Hepatitis B (hsa05161) |
<0.0001 |
Glioma (hsa05214) |
<0.0001 |
Endometrial cancer (hsa05213) |
0.00012 |
Bacterial invasion of epithelial cells (hsa05100) |
0.00013 |
Non-small cell lung cancer (hsa05223) |
0.00015 |
Colorectal cancer (hsa05210) |
0.0002 |
Pancreatic cancer (hsa05212) |
0.0006 |
Small cell lung cancer (hsa05222) |
0.004 |
Central carbon metabolism in cancer (hsa05230) |
0.006 |
Epstein-Barr virus infection (hsa05169) |
0.007 |
Melanoma (hsa05218) |
0.007 |
Bladder cancer (hsa05219) |
0.01 |
HTLV-I infection (hsa05166) |
0.02 |
Acute myeloid leukemia (hsa05221) |
0.03 |
Thyroid cancer (hsa05216) |
0.04 |